gsk2330811
Showing 1 - 4 of 4
Crohns Disease, Crohn's Disease Trial (GSK2330811, Placebo)
Withdrawn
- Crohns Disease
- Crohn's Disease
- GSK2330811
- Placebo
- (no location specified)
Dec 29, 2021
Healthy Volunteers Trial in London (Placebo, GSK2330811)
Completed
- Healthy Volunteers
- Placebo
- GSK2330811
-
London, United KingdomGSK Investigational Site
Apr 28, 2021
Scleroderma, Systemic Trial in Worldwide (GSK2330811, Placebo)
Completed
- Scleroderma, Systemic
- GSK2330811
- Placebo
-
Los Angeles, California
- +13 more
Apr 29, 2021
Scleroderma, Systemic Trial in Cambridge (GSK2330811, Placebo)
Completed
- Scleroderma, Systemic
- GSK2330811
- Placebo
-
Cambridge, United KingdomGSK Investigational Site
May 12, 2017